Ghent University Academic Bibliography

Journal Article
A1
open access

Real-world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis : results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry

A. H. Musters, F. L. van Lookeren, L. F. van der Gang, M. A. Middelkamp-Hup, A. L. Bosma, N. T. Jessurun, Hilde Lapeere (UGent) , A. L. Nguyen, W. Ouwerkerk, Sofie De Schepper (UGent) , et al.

(2024) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 38(3). p.530-542

Add to list

Monoclonal antibodies in type 2 asthma : an updated network meta-analysis

Ahmed Edris Mohamed and Lies Lahousse (UGent)

(2021) MINERVA MEDICA. 112(5). p.573-581

Add to list

Miscellaneous

F-ENO as a biomarker guide for inhaled corticosteroid step down in patients with mild-to-moderate well-controlled asthma

Anh Tuan Dinh-Xuan and Guy Brusselle (UGent)

(2020) EUROPEAN RESPIRATORY JOURNAL. 55(5).

Add to list

Journal Article
A1
open access

Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis

William W Busse, Jorge F Maspero, Yufang Lu, Jonathan Corren, Nicola A Hanania, Bradley E Chipps, Constance H Katelaris, J Mark FitzGerald, Santiago Quirce, Linda B Ford, et al.

(2020) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 125(5). p.565-576

Add to list

Targeting neutrophils in asthma : a therapeutic opportunity?

Joyceline De Volder (UGent) , Lars Vereecke (UGent) , Guy Joos (UGent) and Tania Maes (UGent)

(2020) BIOCHEMICAL PHARMACOLOGY. 182.

Add to list

Journal Article
A1
open access

Quality standards in respiratory real-life effectiveness research : the REal Life EVidence AssessmeNt Tool (RELEVANT) : report from the Respiratory Effectiveness Group - European Academy of Allergy and Clinical Immunology Task Force

Nicolas Roche, Jonathan D Campbell, Jerry A Krishnan, Guy Brusselle (UGent) , Alison Chisholm, Leif Bjermer, Mike Thomas, Eric van Ganse, Maarten van den Berge, George Christoff, et al.

(2019) CLINICAL AND TRANSLATIONAL ALLERGY. 9.

Add to list

Journal Article
A1
open access

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations

David B Price, Sinthia Bosnic-Anticevich, Ian D Pavord, Nicolas Roche, David MG Halpin, Leif Bjermer, Omar S Usmani, Guy Brusselle (UGent) , Simon Wan Yau Ming and Sarang Rastogi

(2019) CLINICAL AND TRANSLATIONAL ALLERGY. 9(1).

Add to list

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52) : results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert (UGent) , Joseph K Han, Martin Desrosiers, Peter W Hellings, Nikhil Amin, Stella E Lee, Joaquim Mullol, Leon S Greos, John V Bosso, Tanya M Laidlaw, et al.

(2019) LANCET. 394(10209). p.1638-1650

Add to list

Journal Article
A1
open access

Conjunctivitis in dupilumab clinical trials

B. Akinlade, E. Guttman‐Yassky, M. Bruin‐Weller, E.L. Simpson, A. Blauvelt, M.J. Cork, E. Prens, P. Asbell, E. Akpek, J. Corren, et al.

(2019) BRITISH JOURNAL OF DERMATOLOGY. 181(3). p.459-473

Add to list

Journal Article
A1
open access

Monoclonal antibodies in type 2 asthma : a systematic review and network meta-analysis

Ahmed Edris Mohamed, Silke De Feyter (UGent) , Tania Maes (UGent) , Guy Joos (UGent) and Lies Lahousse (UGent)

(2019) RESPIRATORY RESEARCH. 20(1).

Academic Bibliography

Real-world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis : results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry

Monoclonal antibodies in type 2 asthma : an updated network meta-analysis

F-ENO as a biomarker guide for inhaled corticosteroid step down in patients with mild-to-moderate well-controlled asthma

Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis

Targeting neutrophils in asthma : a therapeutic opportunity?

Quality standards in respiratory real-life effectiveness research : the REal Life EVidence AssessmeNt Tool (RELEVANT) : report from the Respiratory Effectiveness Group - European Academy of Allergy and Clinical Immunology Task Force

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52) : results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Conjunctivitis in dupilumab clinical trials

Monoclonal antibodies in type 2 asthma : a systematic review and network meta-analysis

Contents

Support

Contact